The Global Precision Medicine Software Market is expected to grow by 2028 at a CAGR of 12.53%.
Rising prevalence of cancer across the world will significantly enhancement the market development within the forthcoming years. Increasing usage of biomarkers for personalized medicine cancer therapy and advancements within the next generation sequencing further propels the precision medicine market evolution positively. Growing prevalence of chronic and rare diseases propel the necessity to grow technologically advanced tools for rapid integration and analysis of patient data. The bioinformatic system assist in translation of knowledge to form effective clinical solutions. Henceforth, the increasing amount of knowledge within the healthcare system will boost the demand for bioinformatics, enhancing the precision medicine market demand. The event of bioinformatics solutions and software will propel immunotherapy development and enhance microbiome analysis thereby, advancing the sector of precision medicine. Additionally, the event of high throughput technologies like next generation sequencing and microarray will pave the way for bioinformatics market growth which will further drive the market demand within the upcoming years.
The global Precision Medicine Software market is segregated on the basis of Application as Rare Diseases, Pharmacogenomics, Oncology, and Other Applications. Based on End User the global Precision Medicine Software market is segmented in Pharmaceutical & Biotechnology Companies, Research Centers and Government Institutes, Healthcare Providers, and Other End Users. Based on Delivery Mode the global Precision Medicine Software market is segmented in Cloud-Based Delivery Mode and On-Premise Delivery Mode.
The global Precision Medicine Software market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Precision Medicine Software market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Human Longevity, Inc, Translational Software Inc, Sunquest Information Systems, Inc, Gene42, Inc, Lifeomic Health, LLC , Syapse, Inc, 2bprecise, LLC, Fabric Genomics, Inc, Foundation Medicine, Inc, Sophia Genetics Sa, and others are among the major players in the global Precision Medicine Software market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Precision Medicine Software Market has been segmented as below:
Precision Medicine Software Market, By Application
Precision Medicine Software Market, By End User
Precision Medicine Software Market, By Delivery Mode
Precision Medicine Software Market, By Region
Precision Medicine Software Market, By Company
The report covers:
Report Scope:
The global Precision Medicine Software market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Precision Medicine Software market share. Major industry players with significant revenue share include Human Longevity, Inc, Translational Software Inc, Sunquest Information Systems, Inc, Gene42, Inc, Lifeomic Health, LLC , Syapse, Inc, 2bprecise, LLC, Fabric Genomics, Inc, Foundation Medicine, Inc, Sophia Genetics Sa, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Point of Care/POC Diagnostics Market
1. Introduction
1.1. Key Take Aways
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
5. Precision Medicine Software Market, By End User
5.1. Key Points
5.2. Pharmaceutical and Biotechnology Companies
5.3. Healthcare Providers
5.4. Research Centers and Academic Institutes
5.5. Other End Users
6. Precision Medicine Software Market, By Application
6.1. Key Points
6.2. Pharmacogenomics
6.3. Rare Diseases
6.4. Oncology
6.5. Other Applications
7. Precision Medicine Software Market, By Delivery Mode
7.1. Key Points
7.2. Cloud-based Delivery Mode
7.3. On-premise Delivery Mode
8. Precision Medicine Software Market, By Region
8.1. Key Points
8.2. North America
8.2.1. U.S
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Spain
8.3.2. Russia
8.3.3. Turkey
8.3.4. Belgium
8.3.5. Netherlands
8.3.6. Germany
8.3.7. France
8.3.8. Italy
8.3.9. Rest of Europe
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia
8.4.5. Rest of Asia Pacific
8.5. Rest of World
8.6. Competitive Landscape
8.7. Introduction
8.8. Recent Developments
8.8.1. Mergers & Acquisitions
8.8.2. New Product Developments
8.8.3. Portfolio/Production Capacity Expansions
8.8.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.8.5. Others
9. Company Profile
9.1. Lifeomic Health, LLC
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Gene42, Inc
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Sunquest Information Systems, Inc
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Translational Software Inc
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Human Longevity, Inc
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. N-Of-One, Inc
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Pieriandx, Inc
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Sophia Genetics Sa
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. Foundation Medicine, Inc
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Fabric Genomics, Inc
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
9.11. 2bprecise, LLC
9.11.1. Company Overview
9.11.2. Product/Service Landscape
9.11.3. Financial Overview
9.11.4. Recent Developments
9.12. Syapse, Inc
9.12.1. Company Overview
9.12.2. Product/Service Landscape
9.12.3. Financial Overview
9.12.4. Recent Developments
The Precision Medicine Software Market has been segmented as below:
Precision Medicine Software Market, By Application
Precision Medicine Software Market, By End User
Precision Medicine Software Market, By Delivery Mode
Precision Medicine Software Market, By Region
Precision Medicine Software Market, By Company
